SCHEMBL6156930

SCHEMBL6156930

COc1ccc(C(CN(C(N)=O)C(C)(OC)OC)O[Si](C)(C)C)cc1OCC1CC1

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 19/20 0.47
PDE4A P27815 7/20 0.41
PDE4C Q08493 7/20 0.41
PDE4D Q08499 7/20 0.41
PARP15 Q460N3 1/20 0.39
PARP10 Q53GL7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6156937 0.83 PDE4B (0.48) PDE4BPDE4APDE4CPDE4D
SCHEMBL8342147 0.78 PDE4B (0.43) PDE4BPDE4APDE4CPDE4DPARP15
SCHEMBL22713924 0.70 PDE4B (0.52) PDE4BPDE4APDE4CPDE4D
SCHEMBL30352570 0.69 PDE4B (0.63) PDE4BPDE4APDE4CPDE4D
SCHEMBL7913450 0.69 PDE4B (0.63) PDE4BPDE4APDE4CPDE4D
SCHEMBL4269812 0.68 PDE4B (0.62) PDE4BPDE4APDE4CPDE4DPARP15
SCHEMBL7916056 0.68 PDE4B (0.57) PDE4BPDE4APDE4CPDE4DPARP15
SCHEMBL7916072 0.68 PDE4B (0.57) PDE4BPDE4APDE4CPDE4DPARP15
SCHEMBL7614635 0.66 PDE4B (0.54) PDE4BPDE4APDE4CPDE4D
SCHEMBL7617504 0.66 PDE4B (0.58) PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832071-B1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA NV (BE) 2005-09-28 EP disclosed
EP-0832071-A1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1998-04-01 EP disclosed
WO-1996031487-A1 1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES HAVING PDE IV AND CYTOKININ INHIBITING ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1996-10-10 WO disclosed